|
Osteoporosis
Citations 81-90 of 99 total displayed.
|
Past content
(since May 1998):
|
- Original Contributions
Low Bone Mineral Density and Risk of Fracture in White Female Nursing Home Residents
- Julie M. Chandler; Sheryl I. Zimmerman; Cynthia J. Girman; Allison R. Martin; William Hawkes; John R. Hebel; Philip D. Sloane; Larry Holder; Jay Magaziner
JAMA 2000; 284: 972-977.
[Abstract]
[Full text]
[PDF]
- Editorials
Bone Health in Nursing Home Residents
- Robert B. Wallace
JAMA 2000; 284: 1018-1019.
[Extract]
[Full text]
[PDF]
- Original Contributions
HMG-CoA Reductase Inhibitors and the Risk of Fractures
- Christoph R. Meier; Raymond G. Schlienger; Marius E. Kraenzlin; Brigitta Schlegel; Hershel Jick
JAMA 2000; 283: 3205-3210.
[Abstract]
[Full text]
[PDF]
- Original Contributions
HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients
- Philip S. Wang; Daniel H. Solomon; Helen Mogun; Jerry Avorn
JAMA 2000; 283: 3211-3216.
[Abstract]
[Full text]
[PDF]
- Special Communications
Treating Nondementia Illnesses in Patients With Dementia
- Daniel J. Brauner; J. Cameron Muir; Greg A. Sachs
JAMA 2000; 283: 3230-3235.
[Abstract]
[Full text]
[PDF]
- Editorials
Do Statins Prevent Both Cardiovascular Disease and Fracture?
- Steven R. Cummings; Douglas C. Bauer
JAMA 2000; 283: 3255-3257.
[Extract]
[Full text]
[PDF]
- Corrections
Incorrect Wording
-
JAMA 1999; 282: 2124.
[Full text]
[PDF]
- Original Contributions
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis: A Randomized Controlled Trial
- Steven T. Harris; Nelson B. Watts; Harry K. Genant; Clark D. McKeever; Thomas Hangartner; Michael Keller; Charles H. Chesnut III; Jacques Brown; Erik F. Eriksen; Mohammad S. Hoseyni; Douglas W. Axelrod; Paul D. Miller; for the Vertebral Efficacy With Risedronate Therapy Study Group
JAMA 1999; 282: 1344-1352.
[Abstract]
[Full text]
[PDF]
- JAMA Patient Page
Prevent hip fractures
-
JAMA 1999; 282: 1396.
[PDF]
[ Key Words ]
- Original Contributions
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial
- Bruce Ettinger; Dennis M. Black; Bruce H. Mitlak; Ronald K. Knickerbocker; Thomas Nickelsen; Harry K. Genant; Claus Christiansen; Pierre D. Delmas; Jose R. Zanchetta; Jacob Stakkestad; Claus C. Glüer; Kathryn Krueger; Fredric J. Cohen; Stephen Eckert; Kristine E. Ensrud; Louis V. Avioli; Paul Lips; Steven R. Cummings; for the Multiple Outcomes of Raloxifene Evaluation Investigators
JAMA 1999; 282: 637-645.
[Abstract]
[Full text]
[PDF]
|
|
